As 2023 comes to a close, I am reminded of the remarkable accomplishments from the last year that give us all reason to celebrate. The NIDDK family – in Bethesda, Maryland; Phoenix, Arizona; and among NIDDK-supported research institutions across the country and world – continued to advance basic and clinical research, helping us move ever closer to answering some of the most vexing questions in our mission.
In this issue, we share updates about some of these important advances and the people behind them.
An NIDDK-funded mouse phenotyping service helps advance metabolic research, NIDDK welcomes two new AAAS Science & Technology Policy Fellows, and more.
Research Updates
Exosomes contribute to chronic inflammation in diabetic wounds, insulin resistance increases in women with restricted sleep, gut bacteria linked to response to type 1 diabetes prevention drug, and more.
Health Information Updates
ICYMI: Prevent diabetes health problems with the National Diabetes Month webpage and toolkit.
Commendations & Commencements
Welcome Dr. Gupta; farewell to Drs. Hamilton and Kuczmarski, and congratulations to Ms. Cochran, Dr. Liang, Dr. Rivers, and all of the 2023 NIDDK Director’s Award winners.
